With the analysis among 3,701 patents, we discovered top 334 key players by total patent application. Boehringer Ingelheim International GmbH, Pfizer Products, Inc., Galapagos NV are dominant in this area. They take 10.19% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 169
Connecticut, United States
Patent: 124
Human Genome Sciences, Inc.
Berlin, Germany
Patent: 65
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 56
Pennsylvania, United States
Patent: 56
New York, United States
Patent: 51
California, United States
Patent: 49
With the analysis among 104 patents, we discovered top 18 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Autobahn Therapeutics, Inc., Optikira LLC are active in this area.
Institut National de la Santé et de la Recherche Médicale
Autobahn Therapeutics, Inc.
California, United States
Patent: 18
Ohio, United States
Patent: 16
Biosplice Therapeutics, Inc.
California, United States
Patent: 15
Basel-Stadt, Switzerland
Patent: 7
ZURICH, Switzerland
Patent: 4
Guangzhou Ruifeng Biological Technology Co., Ltd.
Guangdong Sheng, China
Patent: 4
North Carolina, United States
Patent: 2
Jiangsu Sheng, China
Patent: 2
With the analysis among related 1,136 patents applied in the last 5 years. We discover 266 most active companies in this area. The fast-growing Boehringer Ingelheim International GmbH, Galapagos NV, Bristol Myers Squibb Co. take 13.64% of patent filing during this period.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 68
New York, United States
Patent: 37
New York, United States
Patent: 30
Pennsylvania, United States
Patent: 23
Nanjing Anji Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 21
California, United States
Patent: 21
Corbus Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 21
With the analysis among related 1,136 patents in last 5 years, we discover 193 new entrants. SHY Therapeutics LLC, Vicore Pharma AB, Opsidio LLC are the most active new entrants in this area.
New York, United States
Patent: 30
Pennsylvania, United States
Patent: 23
Nanjing Anji Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 21
Autobahn Therapeutics, Inc.
California, United States
Patent: 18
Purdue Research Foundation
Indiana, United States
Patent: 18
Ohio, United States
Patent: 16
Connecticut, United States
Patent: 15
Chengdu Aoda Biotechnology Co., Ltd.
Tianjin International Biomedical Joint Research Institute Co., Ltd.
Tianjin Shi, China
Patent: 12
With the analysis among 586 patents, we discovered top 97 universities and scientific research institutions by total patent application. La Jolla Cancer Research Foundation, Yale University, University of Bordeaux 1 are dominant in this area. They take 13.82% of the total patent filing.
La Jolla Cancer Research Foundation
California, United States
Patent: 17
Connecticut, United States
Patent: 15
Bretagne, France
Patent: 14
Utah, United States
Patent: 12
Case Western Reserve University
Ohio, United States
Patent: 9
Texas, United States
Patent: 8
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 8
Charité - Universitätsmedizin Berlin
Taipei Medical University
Taiwan Province, China
Patent: 7